scispace - formally typeset
M

Mahdieh Abbasalizad Farhangi

Researcher at Tabriz University of Medical Sciences

Publications -  176
Citations -  4084

Mahdieh Abbasalizad Farhangi is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 138 publications receiving 2121 citations. Previous affiliations of Mahdieh Abbasalizad Farhangi include Tehran University of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017

Christina Fitzmaurice, +627 more
- 27 Sep 2019 - 
TL;DR: The Global Burden of Disease (GBD) study as discussed by the authors has been used to describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning, including cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs).
Journal ArticleDOI

The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017

Lisa M. Force, +170 more
- 01 Sep 2019 - 
TL;DR: The use of DALY-based estimates is crucial in demonstrating that childhood cancer burden represents an important global cancer and child health concern, which disproportionately affects populations in resource-limited settings.
Journal ArticleDOI

Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome.

TL;DR: High systolic blood pressure and fasting serum glucose were potent determinants of intermediate and high risk CVD risk of FRS scoring compared with low risk group and high SBP and FSG were associated with meaningfully increased risk of CVD compared with other parameters.
Journal ArticleDOI

Oral Coenzyme Q10 Supplementation in Patients with Nonalcoholic Fatty Liver Disease: Effects on Serum Vaspin, Chemerin, Pentraxin 3, Insulin Resistance and Oxidative Stress

TL;DR: A potential for coQ10 therapy in improving several anthropometric and biochemical variables in NAFLD is showed and longer studies with higher doses of coQ 10 are required to further evaluate this potential benefit.
Journal ArticleDOI

The effects of Spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial

TL;DR: Spirulina supplementation at a dose of 1 g/d for 12 weeks is effective in modulating body weight and appetite and partly modifies serum lipids, which can further confirm the efficacy of this herbal supplement in control and prevention of obesity and obesity- related disorders.